EP Patent

EP3700889A4 — MALEAT SALTS OF E) -N- (3-CYANO-7-ETHOXY-4 - ((4-PHENOXYPHENYL) AMINO) QUINOLINE-6-YL) -4- (DIMETHYLAMINO) BUT-2-ENAMIDE AND CRYSTALLINE FORMS OF IT

Assigned to Teligene Ltd · Expires 2020-09-02 · 6y expired

What this patent protects

Patent listed against neratinib-maleate.

Drugs covered by this patent

neratinib-maleate (NERATINIB MALEATE)

Patent Metadata

Patent number: EP3700889A4
Jurisdiction: EP
Classification: —
Expires: 2020-09-02
Drug substance claim: No
Drug product claim: No
Assignee: Teligene Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.